Free Trial

CVS Group (LON:CVSG) Receives Buy Rating from Berenberg Bank

CVS Group logo with Consumer Cyclical background

Key Points

  • Berenberg Bank has reissued a "buy" rating for CVS Group with a target price of GBX 2,000, indicating a potential upside of 47.06%.
  • Recent analysis from other firms, including Peel Hunt and Royal Bank of Canada, also supports a positive outlook with target prices of GBX 1,600 and GBX 1,500, respectively.
  • CVS Group's stock recently traded at GBX 1,360 and has shown a range between a fifty-two week low of GBX 791 and a high of GBX 1,648.
  • Five stocks we like better than CVS Group.

CVS Group (LON:CVSG - Get Free Report)'s stock had its "buy" rating reissued by research analysts at Berenberg Bank in a research note issued to investors on Wednesday,Digital Look reports. They presently have a GBX 2,000 price objective on the stock. Berenberg Bank's price objective would indicate a potential upside of 47.06% from the stock's previous close.

Other equities analysts have also recently issued reports about the stock. Peel Hunt reiterated a "buy" rating and set a GBX 1,600 target price on shares of CVS Group in a research note on Tuesday, October 7th. Royal Bank Of Canada reiterated an "outperform" rating and set a GBX 1,500 target price on shares of CVS Group in a research note on Friday, August 29th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, CVS Group currently has an average rating of "Buy" and a consensus target price of GBX 1,700.

Read Our Latest Research Report on CVSG

CVS Group Stock Performance

Shares of CVS Group stock traded down GBX 30 on Wednesday, reaching GBX 1,360. The stock had a trading volume of 231,237 shares, compared to its average volume of 349,800. The business's 50-day moving average price is GBX 1,260.18 and its two-hundred day moving average price is GBX 1,207.54. The company has a debt-to-equity ratio of 110.52, a quick ratio of 0.90 and a current ratio of 1.09. CVS Group has a fifty-two week low of GBX 791 and a fifty-two week high of GBX 1,648. The stock has a market cap of £975.66 million, a P/E ratio of 35,789.47, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02.

CVS Group (LON:CVSG - Get Free Report) last released its earnings results on Tuesday, October 7th. The company reported GBX 80.10 EPS for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. On average, sell-side analysts forecast that CVS Group will post 93.9393939 EPS for the current year.

CVS Group Company Profile

(Get Free Report)

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CVS Group Right Now?

Before you consider CVS Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.

While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.